iFAST Diagnostics
Last verified 2026-06-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $20.3Mattributed |
|---|---|
| Latest round | series-a, $6.3M, 2026-05-27attributed |
| Founded | 2023 |
| Headquarters | United Kingdom |
| Industry | healthtech |
| Stage | series-a |
| Website | ifastdiagnostics.com |
Rapid antimicrobial susceptibility testing delivering results in under three hours to fight drug-resistant infections.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-05-27 | series-a | $6.3M | undisclosed |
Detected tech stack
nginx
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series A, $6.3M | attributed | rss-feeds named as publisher. No document URL on file. |
| Total raised $20.3M | attributed | rss-feeds named as publisher. No document URL on file. |
| Company existence | self-reported | ifastdiagnostics.com, read 2026-06-05 |
| Description | self-reported | ifastdiagnostics.com, read 2026-06-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.